N-ethyl-N-formylhydrazine tumorigenesis in mice

Area of Science:

• Toxicology
• Carcinogenesis
• Chemical Safety

Background:

• N-ethyl-N-formylhydrazine (EFH) is structurally related to N-methyl-N-formylhydrazine, found in edible false morel mushrooms.
• Understanding the toxicological profile of EFH is crucial for assessing potential health risks.

Purpose of the Study:

• To evaluate the carcinogenicity of N-ethyl-N-formylhydrazine (EFH) in a long-term animal study.
• To establish a structure-activity relationship for hydrazine derivatives regarding their carcinogenic potential.

Main Methods:

• Swiss mice were administered a 0.02% solution of EFH in drinking water from 6 weeks of age until natural death.
• Tumor incidence and histopathological diagnoses were recorded for various organs in treated male and female mice.

Main Results:

• EFH administration led to significant tumor development in multiple organs, including lungs (98% in females, 78% in males), blood vessels (94% in females, 64% in males), liver (0% in females, 26% in males), gall bladder (2% in females, 8% in males), and preputial glands (0% in females, 10% in males).
• Histopathological examination revealed various types of tumors, such as adenocarcinomas, angiosarcomas, hepatomas, and carcinomas.

Conclusions:

• The study provides definitive evidence for the carcinogenicity of N-ethyl-N-formylhydrazine (EFH).
• EFH poses a carcinogenic risk, highlighting the importance of evaluating related compounds, including those found in edible mushrooms.